{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:24:53Z","timestamp":1793118293894,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"7984","license":[{"start":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:00:00Z","timestamp":1696982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:00:00Z","timestamp":1696982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2023,10,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Central nervous system tumours represent one of the most lethal cancer types, particularly among children\n                    <jats:sup>1<\/jats:sup>\n                    . Primary treatment includes neurosurgical resection of the tumour, in which a delicate balance must be struck between maximizing the extent of resection and minimizing risk of neurological damage and comorbidity\n                    <jats:sup>2,3<\/jats:sup>\n                    . However, surgeons have limited knowledge of the precise tumour type prior to surgery. Current standard practice relies on preoperative imaging and intraoperative histological analysis, but these are not always conclusive and occasionally wrong. Using rapid nanopore sequencing, a sparse methylation profile can be obtained during surgery\n                    <jats:sup>4<\/jats:sup>\n                    . Here we developed Sturgeon, a patient-agnostic transfer-learned neural network, to enable molecular subclassification of central nervous system tumours based on such sparse profiles. Sturgeon delivered an accurate diagnosis within 40\u2009minutes after starting sequencing in 45 out of 50 retrospectively sequenced samples (abstaining from diagnosis of the other 5 samples). Furthermore, we demonstrated its applicability in real time during 25 surgeries, achieving a diagnostic turnaround time of less than 90\u2009min. Of these, 18 (72%) diagnoses were correct and 7 did not reach the required confidence threshold. We conclude that machine-learned diagnosis based on low-cost intraoperative sequencing can assist neurosurgical decision-making, potentially preventing neurological comorbidity and avoiding additional surgeries.\n                  <\/jats:p>","DOI":"10.1038\/s41586-023-06615-2","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T12:02:04Z","timestamp":1697025724000},"page":"842-849","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":224,"title":["Ultra-fast deep-learned CNS tumour classification during surgery"],"prefix":"10.1038","volume":"622","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0412-5313","authenticated-orcid":false,"given":"C.","family":"Vermeulen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8888-5699","authenticated-orcid":false,"given":"M.","family":"Pag\u00e8s-Gallego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Kester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9683-7494","authenticated-orcid":false,"given":"M. E. G.","family":"Kranendonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Wesseling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Verburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2988-8544","authenticated-orcid":false,"given":"P.","family":"de Witt Hamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. J.","family":"Kooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Dankmeijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8186-338X","authenticated-orcid":false,"given":"J.","family":"van der Lugt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"van Baarsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5587-0439","authenticated-orcid":false,"given":"E. W.","family":"Hoving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1699-8210","authenticated-orcid":false,"given":"B. B. J.","family":"Tops","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0828-3477","authenticated-orcid":false,"given":"J.","family":"de Ridder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,11]]},"reference":[{"key":"6615_CR1","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1056\/NEJMra2116344","volume":"386","author":"AR Cohen","year":"2022","unstructured":"Cohen, A. R. Brain tumors in children. N. Engl. J. Med. 386, 1922\u20131931 (2022).","journal-title":"N. Engl. J. Med."},{"key":"6615_CR2","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00701-013-1653-9","volume":"155","author":"H Duffau","year":"2013","unstructured":"Duffau, H. & Mandonnet, E. The \u2018onco-functional balance\u2019 in surgery for diffuse low-grade glioma: integrating the extent of resection with quality of life. Acta Neurochir. 155, 951\u2013957 (2013).","journal-title":"Acta Neurochir."},{"key":"6615_CR3","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.wneu.2011.06.053","volume":"76","author":"RL Yong","year":"2011","unstructured":"Yong, R. L. & Lonser, R. R. Surgery for glioblastoma multiforme: striking a balance. World Neurosurg. 76, 528\u2013530 (2011).","journal-title":"World Neurosurg."},{"key":"6615_CR4","first-page":"vdab149","volume":"3","author":"L Djirackor","year":"2021","unstructured":"Djirackor, L. et al. Intraoperative DNA methylation classification of brain tumors impacts neurosurgical strategy. Neurooncol. Adv. 3, vdab149 (2021).","journal-title":"Neurooncol. Adv."},{"key":"6615_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/neuonc\/nox149","volume":"20","author":"M Karremann","year":"2018","unstructured":"Karremann, M. et al. Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location. Neuro Oncol. 20, 123\u2013131 (2018).","journal-title":"Neuro Oncol."},{"key":"6615_CR6","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S1470-2045(15)00581-1","volume":"17","author":"EM Thompson","year":"2016","unstructured":"Thompson, E. M. et al. Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis. Lancet Oncol. 17, 484\u2013495 (2016).","journal-title":"Lancet Oncol."},{"key":"6615_CR7","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/pbc.23086","volume":"58","author":"R Venkatramani","year":"2012","unstructured":"Venkatramani, R. et al. Supratentorial ependymoma in children: to observe or to treat following gross total resection? Pediatr. Blood Cancer 58, 380\u2013383 (2012).","journal-title":"Pediatr. Blood Cancer"},{"key":"6615_CR8","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1200\/JCO.2015.65.7825","volume":"34","author":"V Ramaswamy","year":"2016","unstructured":"Ramaswamy, V. et al. Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: a retrospective multicohort analysis. J. Clin. Oncol. 34, 2468\u20132477 (2016).","journal-title":"J. Clin. Oncol."},{"key":"6615_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00401-016-1643-0","volume":"133","author":"KW Pajtler","year":"2017","unstructured":"Pajtler, K. W. et al. The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants. Acta Neuropathol. 133, 5\u201312 (2017).","journal-title":"Acta Neuropathol."},{"key":"6615_CR10","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.wneu.2022.04.073","volume":"164","author":"A Egiz","year":"2022","unstructured":"Egiz, A., Kannas, S. & Asl, S. F. The impact of surgical resection and adjuvant therapy on survival in pediatric patients with atypical teratoid\/rhabdoid tumor: systematic review and pooled survival analysis. World Neurosurg. 164, 216\u2013227 (2022).","journal-title":"World Neurosurg."},{"key":"6615_CR11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/neuonc\/noac177","volume":"25","author":"R Drexler","year":"2023","unstructured":"Drexler, R. et al. DNA methylation subclasses predict the benefit from gross total tumor resection in IDH-wildtype glioblastoma patients. Neuro-Oncol. 25, 315\u2013325 (2023).","journal-title":"Neuro-Oncol."},{"key":"6615_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/neuonc\/nox176","volume":"20","author":"MMJ Wijnenga","year":"2018","unstructured":"Wijnenga, M. M. J. et al. The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis. Neuro-Oncol. 20, 103\u2013112 (2018).","journal-title":"Neuro-Oncol."},{"key":"6615_CR13","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev-pathol-042220-022304","volume":"17","author":"A Papanicolau-Sengos","year":"2022","unstructured":"Papanicolau-Sengos, A. & Aldape, K. DNA methylation profiling: an emerging paradigm for cancer diagnosis. Annu. Rev. Pathol. 17, 295\u2013321 (2022).","journal-title":"Annu. Rev. Pathol."},{"key":"6615_CR14","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","volume":"555","author":"D Capper","year":"2018","unstructured":"Capper, D. et al. DNA methylation-based classification of central nervous system tumours. Nature 555, 469\u2013474 (2018).","journal-title":"Nature"},{"key":"6615_CR15","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40478-019-0668-8","volume":"7","author":"Z Jaunmuktane","year":"2019","unstructured":"Jaunmuktane, Z. et al. Methylation array profiling of adult brain tumours: diagnostic outcomes in a large, single centre. Acta Neuropathol. Commun. 7, 24 (2019).","journal-title":"Acta Neuropathol. Commun."},{"key":"6615_CR16","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/nan.12610","volume":"46","author":"LP Priesterbach-Ackley","year":"2020","unstructured":"Priesterbach-Ackley, L. P. et al. Brain tumour diagnostics using a DNA methylation-based classifier as a diagnostic support tool. Neuropathol. Appl. Neurobiol. 46, 478\u2013492 (2020).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"6615_CR17","doi-asserted-by":"publisher","first-page":"692","DOI":"10.4161\/epi.6.6.16196","volume":"6","author":"J Sandoval","year":"2011","unstructured":"Sandoval, J. et al. Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics 6, 692\u2013702 (2011).","journal-title":"Epigenetics"},{"key":"6615_CR18","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2217\/epi.15.114","volume":"8","author":"S Moran","year":"2016","unstructured":"Moran, S., Arribas, C. & Esteller, M. Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome enriched in enhancer sequences. Epigenomics 8, 389\u2013399 (2016).","journal-title":"Epigenomics"},{"key":"6615_CR19","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1056\/NEJMc2112090","volume":"386","author":"JE Gorzynski","year":"2022","unstructured":"Gorzynski, J. E. et al. Ultrarapid nanopore genome sequencing in a critical care setting. N. Engl. J. Med. 386, 700\u2013702 (2022).","journal-title":"N. Engl. J. Med."},{"key":"6615_CR20","doi-asserted-by":"publisher","unstructured":"Sagniez, M. et al. Real-time molecular classification of leukemias. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2022.06.22.22276550 (2022).","DOI":"10.1101\/2022.06.22.22276550"},{"key":"6615_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s10038-019-0679-0","volume":"65","author":"L Xu","year":"2020","unstructured":"Xu, L. & Seki, M. Recent advances in the detection of base modifications using the Nanopore sequencer. J. Hum. Genet. 65, 25\u201333 (2020).","journal-title":"J. Hum. Genet."},{"key":"6615_CR22","doi-asserted-by":"publisher","unstructured":"Kuschel, L. P. et al. Robust methylation-based classification of brain tumors using nanopore sequencing. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2021.03.06.21252627 (2021).","DOI":"10.1101\/2021.03.06.21252627"},{"key":"6615_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23778-6","volume":"12","author":"ZW-S Yuen","year":"2021","unstructured":"Yuen, Z. W.-S. et al. Systematic benchmarking of tools for CpG methylation detection from nanopore sequencing. Nat. Commun. 12, 3438 (2021).","journal-title":"Nat. Commun."},{"key":"6615_CR24","unstructured":"Guo, C., Pleiss, G., Sun, Y. & Weinberger, K. Q. On calibration of modern neural networks. In Proc. 34th International Conference on Machine Learning, Vol. 70 (eds Precup, D. & Teh, Y. W.) 1321\u20131330 (Proceedings of Machine Learning Research, 2017)."},{"key":"6615_CR25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00401-018-1879-y","volume":"136","author":"D Capper","year":"2018","unstructured":"Capper, D. Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience. Acta Neuropathol. 136, 181\u2013210 (2018).","journal-title":"Acta Neuropathol."},{"key":"6615_CR26","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1093\/neuonc\/noab134","volume":"23","author":"N Verburg","year":"2021","unstructured":"Verburg, N. et al. Spatial concordance of DNA methylation classification in diffuse glioma. Neuro-Oncol. 23, 2054\u20132065 (2021).","journal-title":"Neuro-Oncol."},{"key":"6615_CR27","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00401-017-1743-5","volume":"134","author":"P Euskirchen","year":"2017","unstructured":"Euskirchen, P. et al. Same-day genomic and epigenomic diagnosis of brain tumors using real-time nanopore sequencing. Acta Neuropathol. 134, 691\u2013703 (2017).","journal-title":"Acta Neuropathol."},{"key":"6615_CR28","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/jamaoncol.2019.6143","volume":"6","author":"AM Molinaro","year":"2020","unstructured":"Molinaro, A. M. et al. Association of maximal extent of resection of contrast-enhanced and non-contrast-enhanced tumor with survival within molecular subgroups of patients with newly diagnosed glioblastoma. JAMA Oncol. 6, 495\u2013503 (2020).","journal-title":"JAMA Oncol."},{"key":"6615_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.nec.2020.09.006","volume":"32","author":"DP Cahill","year":"2021","unstructured":"Cahill, D. P. Extent of resection of glioblastoma: a critical evaluation in the molecular era. Neurosurg. Clin. N. Am. 32, 23\u201329 (2021).","journal-title":"Neurosurg. Clin. N. Am."},{"key":"6615_CR30","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S1470-2045(06)70665-9","volume":"7","author":"W Stummer","year":"2006","unstructured":"Stummer, W. et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 7, 392\u2013401 (2006).","journal-title":"Lancet Oncol."},{"key":"6615_CR31","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nmeth.3930","volume":"13","author":"M Loose","year":"2016","unstructured":"Loose, M., Malla, S. & Stout, M. Real-time selective sequencing using nanopore technology. Nat. Methods 13, 751\u2013754 (2016).","journal-title":"Nat. Methods"},{"key":"6615_CR32","unstructured":"WHO Classification of Tumours Editorial Board. Central Nervous System Tumours (International Agency for Research on Cancer, 2022)."},{"key":"6615_CR33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41746-020-00323-1","volume":"3","author":"N Rieke","year":"2020","unstructured":"Rieke, N. et al. The future of digital health with federated learning. npj Digit. Med. 3, 119 (2020).","journal-title":"npj Digit. Med."},{"key":"6615_CR34","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1586\/14737140.2013.840090","volume":"13","author":"A Bregy","year":"2013","unstructured":"Bregy, A. et al. The role of Gliadel wafers in the treatment of high-grade gliomas. Expert Rev. Anticancer Ther. 13, 1453\u20131461 (2013).","journal-title":"Expert Rev. Anticancer Ther."},{"key":"6615_CR35","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.3390\/ijms23031711","volume":"23","author":"EN Mathew","year":"2022","unstructured":"Mathew, E. N., Berry, B. C., Yang, H. W., Carroll, R. S. & Johnson, M. D. Delivering therapeutics to glioblastoma: overcoming biological constraints. Int. J. Mol. Sci. 23, 1711 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"6615_CR36","unstructured":"Loshchilov, I & Hutter, F. Decoupled Weight Decay Regularization. In Proc. 7th International Conference on Learning Representations (ICLR, 2019)."},{"key":"6615_CR37","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1101\/gr.175141.114","volume":"24","author":"I Scheinin","year":"2014","unstructured":"Scheinin, I. et al. DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly. Genome Res. 24, 2022\u20132032 (2014).","journal-title":"Genome Res."},{"key":"6615_CR38","unstructured":"Seshan, V. E. & Olshen, A. DNAcopy: DNA copy number data analysis. R package version (2023); https:\/\/bioconductor.org\/packages\/release\/bioc\/html\/DNAcopy.html."},{"key":"6615_CR39","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841\u2013842 (2010).","journal-title":"Bioinformatics"},{"key":"6615_CR40","doi-asserted-by":"publisher","unstructured":"Pag\u00e8s-Gallego, M. Python code for the development of Sturgeon. Zenodo https:\/\/doi.org\/10.5281\/zenodo.8224892 (2023).","DOI":"10.5281\/zenodo.8224892"},{"key":"6615_CR41","doi-asserted-by":"publisher","unstructured":"Pag\u00e8s-Gallego, M. & Vermeulen, C. Sturgeon Python package and R custom scripts for CNS classification. Zenodo https:\/\/doi.org\/10.5281\/zenodo.8224879 (2023).","DOI":"10.5281\/zenodo.8224879"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-023-06615-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-023-06615-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-023-06615-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T07:05:14Z","timestamp":1698735914000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-023-06615-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,11]]},"references-count":41,"journal-issue":{"issue":"7984","published-print":{"date-parts":[[2023,10,26]]}},"alternative-id":["6615"],"URL":"https:\/\/doi.org\/10.1038\/s41586-023-06615-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.01.25.23284813","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,11]]},"assertion":[{"value":"10 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.d.R., M.P.-G. and CV are inventors on a patent covering the development of Sturgeon. J.d.R. is co-founder and director of Cyclomics, a genomics company. L.K., M.E.G.K., P.W., N.V., P.d.W.H., E.J.K., L.D., J.v.d.L., K.v.B., E.W.H. and B.B.J.T. declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}